Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bendroflumethiazide/potassium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bendroflumethiazide 2.5mg/Pot chlor 573mg MR tab
0202080B0AAAAAA
|
Bendroflumeth/potassium | Bendroflumethiazide/potassium | Cardiovascular System | No data available |
|
Bendroflumethiazide 2.5mg/Pot chlor 630mg MR tab
0202080B0AAABAB
|
Bendroflumeth/potassium | Bendroflumethiazide/potassium | Cardiovascular System | No data available |
|
Centyl K modified-release tablets
0202080B0BBAAAA
|
Centyl K | Bendroflumethiazide/potassium | Cardiovascular System | No data available |
|
Neo-Naclex-K modified-release tablets
0202080B0BCAAAB
|
Neo-Naclex-K | Bendroflumethiazide/potassium | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.